ampelopsin has been researched along with chitosan in 2 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 27,648 | 232 | 21,257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z; Ding, C; Ding, Q; Liu, W; Liu, X; Peng, X; Sun, S; Zhao, Y; Zheng, Y | 1 |
| Dong, L; Fu, H; Li, M; Li, Y; Luo, J; Shi, F; Shu, G; Tang, H; Yan, Q; Ye, G; Yin, H; Zhang, W; Zhao, L; Zhao, X; Zhong, X | 1 |
2 other study(ies) available for ampelopsin and chitosan
| Article | Year |
|---|---|
A poloxamer/hyaluronic acid/chitosan-based thermosensitive hydrogel that releases dihydromyricetin to promote wound healing.
Topics: Antioxidants; Chitosan; Flavonols; Humans; Hyaluronic Acid; Hydrogels; Poloxamer; Wound Healing | 2022 |
Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin.
Topics: Acute Kidney Injury; Chitosan; Cisplatin; Humans; Nanoparticles; Particle Size | 2023 |